ProShare Advisors’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

ProShare Advisors’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-12,716	Closed	-$463K	–	1729
2016 Q4	$463K	Buy	+12,716	New	+$450K	0.01%	1114

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

ProShare Advisors's CLCD Position: Q1 2017 in Review

ProShare Advisors sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 12,716 shares — an estimated $463K sold.

ProShare Advisors first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $463K in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

ProShare Advisors reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
ProShare Advisors sold 12,716 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $463K.
ProShare Advisors first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
ProShare Advisors's CoLucid Pharmaceuticals, Inc. position peaked at $463K in Q4 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on ProShare Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.